軟部組織修復市場：デモグラフィ、軟部組織損傷の種類、治療方法、地域別、2026年～2032年

軟部組織修復市場の評価、2026年～2032年

スポーツ関連傷害の増加や高齢化により、外科手術や修復製品に対する需要が高まっています。さらに、低侵襲手術手技の認知度向上により、より多くの患者がこれらの手術を選択するようになり、市場成長が加速し、2024年には194億7,000万米ドル、2032年には291億3,000万米ドルに達します。

新しい縫合糸、移植片、固定器具の開発など、医療技術の進歩により、軟部組織手術の効果と結果が向上しており、2026年から2032年までのCAGRは約5.17%で成長しています。

軟部組織修復市場定義/概要

軟部組織修復には、筋肉、腱、靭帯、筋膜などの損傷した軟部組織の完全性と機能を修復するための外科的処置と非外科的処置の両方が含まれます。スポーツ医学や整形外科手術、再建手術や創傷治癒はすべて、さまざまな怪我や病気の治療に用いられています。生体材料、再生医療、低侵襲手技の進歩により、治癒結果の改善や回復期間の短縮が可能になり、軟部組織修復の未来は楽観的であるように思われます。さらに、スマートテクノロジーとオーダーメイド医療を組み合わせることで、オーダーメイド治療が実現し、臨床における軟部組織修復の可能性が高まるかもしれないです。

低侵襲手術技術の認知度向上は軟部組織修復市場を促進するか？

低侵襲手術（MIS）に対する認識と利用の高まりは、軟部組織修復市場を大きく前進させています。米国低侵襲手術学会（ASMIS）によると、軟部組織修復のためのMIS手術の使用は2024年には2022年比で42％増加し、北米だけで850万件以上の治療が行われました。2024年2月、国際関節鏡・膝関節外科・整形外科スポーツ医学会（International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine）は、2022年2月の58％から増加し、現在、全世界の軟部組織手術の73％が低侵襲手術を使用していると発表しました。さらに、世界保健機関（WHO）は2024年3月、従来の開腹手術に比べ、MIS手術は回復時間を65％、入院期間を48％短縮できることを示す統計を発表しました。

2024年1月、ジョンソン・エンド・ジョンソンのデピューシンセは、MIS部門の収益が38％増加したことを受け、次世代の低侵襲軟部組織修復技術の開発に8億米ドルを投資すると発表しました。2024年3月、メドトロニックが先進関節鏡修復システムを発表し、低侵襲手術機器部門の前年比45％増を挙げました。2024年2月、欧州連合のヘルスケア・イノベーション・イニシアチブは、軟部組織修復におけるMIS技術の進歩に3億2,000万ユーロを拠出しました。さらに、ボストン・サイエンティフィック社は2024年12月、同社の低侵襲軟部組織修復製品ラインの世界売上高が52％増加したと発表しました。2024年3月、中国国家衛生委員会は包括的な医療近代化計画を発表し、低侵襲手術法の普及に23億米ドルを投資し、2026年までにMIS手術を40％増加させる目標を掲げました。

高まる規制上のハードルは軟部組織修復市場の成長を妨げるか？

規制上の制約の増大は、製品開発と承認に要する時間を長期化させることにより、軟部組織修復業界を大きく制限する可能性があります。厳格な臨床試験や詳細な安全性評価といった規制機関の厳しい基準は、新規製品の上市を遅らせる原因となります。これはメーカーの価格を引き上げるだけでなく、複雑な規制プロセスを交渉する手段を持たない中小企業を阻害し、技術革新を窒息させ、市場競争力を低下させる。

さらに、特に再生医療のような新しい産業では、絶えず変化する規制の性質が、企業にさらなる不確実性をもたらしています。常に新しい要件に対応しなければならないため、コンプライアンス費用が投資を抑制し、新技術の採用を妨げる可能性があります。その結果、治療の選択肢は遅い速度で進化し、患者の転帰に悪影響を及ぼし、軟部組織修復市場の総成長の可能性を制限することになりかねないです。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 軟部組織修復市場：デモグラフィ別

• 年齢
• 性別
• 社会経済的地位

第5章 軟部組織修復市場：軟部組織損傷の種類別

• スポーツ傷害
• 外傷性損傷
• 変性疾患

第6章 軟部組織修復市場：治療方法別

• 外科手術 vs非外科手術
• 生物学的製剤vs合成素材
• リハビリテーションサービス

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Johnson & Johnson
• Smith & Nephew plc
• Medtronic plc
• Stryker Corporation
• Integra LifeSciences Corporation
• Acelity L.P. Inc.（3M Company）
• Arthrex, Inc.
• Zimmer Biomet Holdings, Inc.
• Olympus Corporation
• Boston Scientific Corporation

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Soft Tissue Repair Market Valuation - 2026-2032

The increased prevalence of sports-related injuries, combined with an aging population, is boosting demand for surgical procedures and repair products. Furthermore, increasing awareness of minimally invasive surgical techniques encourages more patients to choose these operations, accelerating market growth is fueling USD 19.47 Billion in 2024 and reaching USD 29.13 Billion by 2032.

Advances in medical technology, such as the creation of novel sutures, grafts, and fixation devices, are improving the efficacy and results of soft tissue procedures is grow at a CAGR of about 5.17% from 2026 to 2032

Soft Tissue Repair Market: Definition/ Overview

Soft tissue repair encompasses both surgical and non-surgical procedures for repairing the integrity and function of damaged soft tissues, such as muscles, tendons, ligaments, and fascia. Sports medicine and orthopedic surgery, as well as reconstructive procedures and wound healing, are all used to treat a wide range of injuries and ailments. The future of soft tissue repair seems optimistic, with advances in biomaterials, regenerative medicine, and minimally invasive procedures ready to improve healing results and shorten recovery periods. Furthermore, the combination of smart technologies and customized medicine may result in tailored treatments, increasing the potential of soft tissue restoration in clinical practice.

Will Increasing Awareness of Minimally Invasive Surgical Techniques Propel the Soft Tissue Repair Market?

The increasing awareness and use of minimally invasive surgical (MIS) procedures is considerably propelling the soft tissue repair market forward. According to the American Society for Minimally Invasive Surgery (ASMIS), the use of MIS operations for soft tissue repair grew by 42% in 2024 compared to 2022, with over 8.5 million treatments conducted in North America alone. In February 2024, the International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine announced that 73% of all soft tissue surgeries worldwide now use minimally invasive procedures, up from 58% in February 2022. Furthermore, the World Health Organization (WHO) published statistics in March 2024 demonstrating that MIS operations save recovery time by 65% and hospital stays by 48% compared with to traditional open surgeries.

In January 2024 Johnson & Johnson's DePuy Synthes announced a USD 800 Million investment in developing next-generation minimally invasive soft tissue repair technologies, following a 38% growth in MIS division revenue. Medtronic released their advanced arthroscopic repair system in March 2024, citing a 45% year-over-year increase in the minimally invasive surgical instruments segment. In February 2024, the European Union's Healthcare Innovation Initiative committed €320 million to advance MIS technologies in soft tissue restoration. Furthermore, Boston Scientific stated in December 2024 that their minimally invasive soft tissue repair product line saw a 52% increase in global sales. In March 2024, the Chinese National Health Commission unveiled a comprehensive healthcare modernization plan, investing $2.3 billion in promoting minimally invasive surgical methods, with a goal of increasing MIS procedures by 40% by 2026.

Will Growing Regulatory Hurdles Hinder the Growth of the Soft Tissue Repair Market?

Growing regulatory constraints can significantly restrict the soft tissue repair industry by lengthening product development and approval times. Regulatory bodies' stringent standards, such as rigorous clinical trials and detailed safety assessments, can cause delays in the marketing of novel products. This not only raises prices for manufacturers, but it also inhibits smaller businesses that may lack the means to negotiate complex regulatory processes, thus suffocating innovation and decreasing market competitiveness.

Furthermore, the continually changing nature of rules, particularly in new industries such as regenerative medicine, creates further uncertainty for businesses. Because they must constantly adjust to new requirements, compliance expenses can discourage investment and hinder the adoption of new technologies. As a result, treatment choices evolve at a slower rate, which can have a negative impact on patient outcomes and limit the soft tissue repair market's total growth potential.

Category-Wise Acumens

Will Rising Incidence of Sports Injuries Propel the Soft Tissue Repair Market?

The rising frequency of sports injuries is expected to considerably propel the soft tissue repair market, owing to increased participation in sports and recreational activities among all age groups. As more people participate in high-impact sports, the demand for effective treatment alternatives for injuries such ligament tears, tendonitis, and muscular strains increases. According to recent projections, the worldwide sports medicine industry, which includes soft tissue repair, is predicted to reach USD 9.7 Billion by 2025, demonstrating the growing demand for new repair options. Companies such as Medtronic and Johnson & Johnson are aggressively developing new surgical devices and biologics to treat these injuries, which is driving market growth.

Furthermore, government attempts to promote sports and physical activity may contribute to this growing tendency. For instance, in March 2024, the United States government launched a new plan to encourage youth sports participation, including funding for sports programs and injury prevention education. Such efforts not only inspire more individuals to participate in sports, but they also raise the probability of injuries, driving up demand for soft tissue repair solutions. This combination of increased sports involvement and improved treatment choices sets the soft tissue repair industry for strong growth in the next years.

However, the fastest-growing group is degenerative ailments, which are being driven by an aging population and an increasing prevalence of chronic diseases like osteoarthritis. As people become more aware of treatment alternatives for illnesses like tendinitis and ligament tears, this area is likely to grow quickly. Traumatic injuries continue to be a substantial market segment, but their growth rate is slower than that of degenerative illnesses, which are gaining recognition in both the clinical and patient populations.

Will Rising Aging Population Fuel the Soft Tissue Repair Market?

The aging population is likely to drive the soft tissue repair market, as older persons are more prone to degenerative disorders and injuries that require repair interventions. Age-related conditions, such as tendon deterioration and joint difficulties, may necessitate surgical interventions for effective therapy. In April 2024According to a World Health Organization research released, the global population aged 65 and older is expected to quadruple by 2050, indicating an increased demand for medical interventions, including soft tissue repair solutions. Companies such as Stryker and Zimmer Biomet are actively extending their product lines to cater to this demographic, with an emphasis on breakthrough surgical procedures and materials that improve recovery in older patients.

Additionally, government measures targeted at addressing the healthcare needs of the aging population contribute to market growth. In January 2024, the United States Department of Health and Human treatments unveiled a new framework for enhancing older individuals' access to healthcare, which includes increased financing for orthopedic and rehabilitation treatments. This emphasis on geriatric care not only highlights the importance of effective soft tissue repair choices, but it also pushes industry companies to engage in R&D. The soft tissue repair market is expected to increase significantly in the future years as demand for therapies rises in tandem with the aging population.

Young adults, particularly those who participate in sports and fitness activities, are the fastest-growing group. This surge is being driven by increased sports involvement and a growing awareness of injuries among young people. Furthermore, socioeconomic status is important, with higher-income persons often having greater access to modern treatment alternatives.

Country/Region-wise

Will Rising Investment In Medical Technology in North America Drive the Soft Tissue Repair Market?

The growing investment in medical technology in North America is significantly driving the growth of the soft tissue repair market, with significant funds moving into research, development, and commercialization of improved treatment solutions. According to the Medical Device Innovation Consortium (MDIC), North American investment in medical technology will reach USD 52.4 Billion by 2024, with soft tissue repair technologies accounting for USD 7.8 Billion. In February 2024, the American Association of Tissue Banks stated that demand for soft tissue allografts climbed by 34% in 2024 compared to 2022. In March 2024, the US Centers for Medicare & Medicaid Services (CMS) announced that reimbursement coverage for minimally invasive soft tissue operations increased by 28% in 2024, with approved procedures rising from 2,800 to 3,584.

In January 2024, Smith & Nephew announced a $600 million investment in its Tennessee factory to enhance production of innovative soft tissue repair devices, following a 42% growth in sports medicine division revenue. In March 2024, Arthrex announced a new USD 450 Million research facility in Florida dedicated to soft tissue repair technologies, with plans to create 1,200 specialist jobs. In February 2024, the US National Institutes of Health (NIH) launched a USD 275 Million grant program for soft tissue repair research activities. In March 2024 while Zimmer Biomet received FDA approval for their innovative biological scaffold technology, which is supported by a USD 300 Million investment in R&D.

Will Increasing Healthcare Expenditure in Asia Pacific Propel the Soft Tissue Repair Market?

Increasing healthcare spending in Asia-Pacific is expected to significantly boost the soft tissue repair market. As countries in this region continue to invest in healthcare infrastructure and access to new medical technologies, there is an increasing demand for effective soft tissue injury treatments. For instance, In March 2024 the Asian Development Bank stated that healthcare spending in Asia-Pacific is expected to exceed USD 1 Trillion by 2025, driven by a growing middle class and increased awareness of health issues. Companies such as Medtronic and Arthrex are growing their position in this market by introducing novel products that are suited to the region's unique needs.

Furthermore, government actions to improve healthcare access boost market growth. In July 2024, the Indian government announced the "Health Systems for a New India" project, which includes aims to improve orthopedic and rehabilitation care. This program not only demonstrates the dedication to improving healthcare, but it also presents chances for companies who specialize in soft tissue healing. As healthcare costs rise and more resources are committed to treating soft tissue injuries and diseases, the market in Asia-Pacific is predicted to grow significantly.

Competitive Landscape

The competitive landscape of the soft tissue repair market is characterized by a mix of established companies and emerging players focusing on innovation and specialization. Companies are increasingly investing in research and development to introduce advanced biomaterials, minimally invasive techniques, and regenerative medicine approaches, enhancing treatment outcomes. Strategic partnerships, mergers, and acquisitions are common as firms seek to expand their product portfolios and geographical reach. Additionally, there is a growing emphasis on personalized medicine, which is shaping product development and marketing strategies. The market is also influenced by regulatory factors, reimbursement policies, and changing patient demographics, prompting companies to adapt their approaches to stay competitive and meet evolving consumer needs.

Some of the prominent players operating in the soft tissue repair market Include:

Johnson & Johnson

Smith & Nephew plc

Medtronic plc

Stryker Corporation

Integra LifeSciences Corporation

Acelity L.P., Inc.

Arthrex, Inc.

Zimmer Biomet Holdings, Inc.

Olympus Corporation

Boston Scientific Corporation

Latest Developments

In February 2024, Smith & Nephew introduced a new line of sophisticated wound care solutions that contain soft tissue repair components. These products aim to improve patient outcomes by enhancing moisture management and infection control, which aligns with the growing demand for comprehensive wound treatment solutions.

In April 2024, Baxter stated that it was developing a unique biologic scaffold for soft tissue regeneration. This medication is intended to enhance healing and tissue regeneration, meeting an important need in difficult soft tissue repair instances.

Soft Tissue Repair Market, By Category

• Demography:
• Age
• Gender
• Socioeconomic Status
• Type of Soft Tissue Injury:
• Sports Injuries
• Traumatic Injuries
• Degenerative Conditions
• Methods of Treatment:
• Surgical vs. Non-Surgical
• Biologics vs. Synthetic Materials
• Rehabilitation Services
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Soft Tissue Repair Market, By Demography

• Age
• Gender
• Socioeconomic Status

5. Soft Tissue Repair Market, By Type of Soft Tissue Injury

• Sports Injuries
• Traumatic Injuries
• Degenerative Conditions

6. Soft Tissue Repair Market, By Methods of Treatment

• Surgical vs. Non-Surgical
• Biologics vs. Synthetic Materials
• Rehabilitation Services

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Johnson & Johnson
• Smith & Nephew plc
• Medtronic plc
• Stryker Corporation
• Integra LifeSciences Corporation
• Acelity L.P. Inc. (3M Company)
• Arthrex, Inc.
• Zimmer Biomet Holdings, Inc.
• Olympus Corporation
• Boston Scientific Corporation

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References